9/14/2026
Psyence BioMed forms Texas entity for U.S. ibogaine research
Texas Ibogaine Research Corporation to spearhead U.S. ibogaine development efforts.
Topic archive
neuroplastogens
3 stories
9/1/2026
Barrow, ASU launch clinical trial for ibogaine in the US
The study aims to explore ibogaine's potential for treating PTSD and addiction.
8/21/2026
Johnson & Johnson invests in Delix Therapeutics
Investment in neuroplastogen company highlights growing interest in non-hallucinogenic psychedelics.